ALK+ Lymphoma: Clinico-Pathological Findings and Outcome B Falini, S Pileri, PL Zinzani, A Carbone, V Zagonel, C Wolf-Peeters, ...
Blood, The Journal of the American Society of Hematology 93 (8), 2697-2706, 1999
820 1999 Second-order moving average and scaling of stochastic time series E Alessio, A Carbone, G Castelli, V Frappietro
The European Physical Journal B-Condensed Matter and Complex Systems 27 (2 …, 2002
523 2002 Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled … V Galimberti, BF Cole, G Viale, P Veronesi, E Vicini, M Intra, G Mazzarol, ...
The Lancet Oncology 19 (10), 1385-1393, 2018
485 2018 HIV-associated lymphomas and gamma-herpesviruses A Carbone, E Cesarman, M Spina, A Gloghini, TF Schulz
Blood, The Journal of the American Society of Hematology 113 (6), 1213-1224, 2009
447 2009 A multicenter study of treatment of primary CNS lymphoma AJM Ferreri, M Reni, F Pasini, A Calderoni, U Tirelli, A Pivnik, GM Aondio, ...
Neurology 58 (10), 1513-1520, 2002
443 2002 EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ...
The American journal of pathology 174 (2), 661-670, 2009
422 2009 Measurement of the Ratio of Branching Fractions B (B c+→ J/ψ τ+ ν τ)/B (B c+→ J/ψ μ+ ν μ) R Aaij, B Adeva, M Adinolfi, Z Ajaltouni, S Akar, J Albrecht, F Alessio, ...
Physical review letters 120 (12), 121801, 2018
397 2018 EBV-associated lymphoproliferative disorders: classification and treatment A Carbone, A Gloghini, G Dotti
The oncologist 13 (5), 577-585, 2008
381 2008 ALK expression defines a distinct group of T/null lymphomas (“ALK lymphomas”) with a wide morphological spectrum B Falini, B Bigerna, M Fizzotti, K Pulford, SA Pileri, G Delsol, A Carbone, ...
The American journal of pathology 153 (3), 875-886, 1998
372 1998 Hypermethylation of the DNA Repair Gene O 6 -Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma M Esteller, G Gaidano, SN Goodman, V Zagonel, D Capello, B Botto, ...
Journal of the National Cancer Institute 94 (1), 26-32, 2002
362 2002 The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape D Aldinucci, A Gloghini, A Pinto, R De Filippi, A Carbone
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
355 2010 Analysis of the resonant components in R Aaij, C Abellan Beteta, B Adeva, M Adinolfi, C Adrover, A Affolder, ...
Physical Review D—Particles, Fields, Gravitation, and Cosmology 86 (5), 052006, 2012
342 2012 Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study C Simonelli, M Spina, R Cinelli, R Talamini, R Tedeschi, A Gloghini, ...
Journal of Clinical Oncology 21 (21), 3948-3954, 2003
324 2003 Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts U Klein, A Gloghini, G Gaidano, A Chadburn, E Cesarman, ...
Blood, The Journal of the American Society of Hematology 101 (10), 4115-4121, 2003
300 2003 Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection S De Vita, C Sacco, D Sansonno, A Gloghini, F Dammacco, M Crovatto, ...
Blood, The Journal of the American Society of Hematology 90 (2), 776-782, 1997
287 1997 Follicular lymphoma A Carbone, S Roulland, A Gloghini, A Younes, G von Keudell, ...
Nature reviews Disease primers 5 (1), 83, 2019
282 2019 Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus–associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid … V De Re, S De Vita, A Marzotto, M Rupolo, A Gloghini, B Pivetta, ...
Blood, The Journal of the American Society of Hematology 96 (10), 3578-3584, 2000
281 2000 Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus–related lymphomas A Carbone, A Gloghini, LM Larocca, D Capello, F Pierconti, V Canzonieri, ...
Blood, The Journal of the American Society of Hematology 97 (3), 744-751, 2001
278 2001 MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival B Zheng, P Fiumara, YV Li, G Georgakis, V Snell, M Younes, JN Vauthey, ...
Blood 102 (3), 1019-1027, 2003
274 2003 Lymphomas expressing ALK fusion protein (s) other than NPM-ALK B Falini, K Pulford, A Pucciarini, A Carbone, C De Wolf-Peeters, J Cordell, ...
Blood, The Journal of the American Society of Hematology 94 (10), 3509-3515, 1999
269 1999 